Journal of Experimental & Clinical Cancer Research · 2018 · 68 citations · 29 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAngiogenesisAngiogenesis In CancerAntitumor T Cell ResponsesCancer ImmunotherapyInterferon ResponsesT Cell Responses To TumorsAnticancer ActivityAntitumor Interferon ResponsesInterferon Gamma ProductionInterferon Gamma ResponseInterferon ProductionInterferon-gamma ResponsesT Cell-independent ActivationTumor Immune Cell Infiltration
BACKGROUND: Antiangiogenic agents are commonly used in lung and colon cancer treatments, however, rapid development of drug resistance limits their efficacy. METHODS: Lentinan (LNT) is a biologically active compound extracted from Lentinus edodes. The effects of LNT on tumor angiogenesis were evaluated by immunohistochemistry in murine LAP0297 lung and CT26 colorectal tumor models. The impacts of LNT on immune cells and gene expression in tumor tissues were determined by flow cytometry, qPCR, and ELISA. Nude mice and IFNγ blockade were used to investigate the mechanism of LNT affecting on tumor angiogenesis. The data sets were compared using two-tailed student's t tests or ANOVA. RESULTS: We found that LNT inhibited tumor angiogenesis and the growth of lung and colon cancers. LNT treatments elevated the expression of angiostatic factors such as IFNγ and also increased tumor infiltration of IFNγ-expressing T cells and myeloid cells. Interestingly, IFNγ blockade, but not T cell deficiency, reversed the effects of LNT treatments on tumor blood vessels. Moreover, long-lasting LNT administration persistently suppressed tumor angiogenesis and inhibited tumor growth. CONCLUSIONS: LNT inhibits tumor angiogenesis by increasing IFNγ production and in a T cell-independent manner. Our findings suggest that LNT could be developed as a new antiangiogenic agent for long-term treatment of lung and colon cancers.
29
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Transplacental Carcinogenesis by Stilbestrol
Judah Folkman · New England Journal of Medicine · 1971 · 2.6K citations
Pharmacy, Oncology, Toxicology +17
Yuhui Huang, Jian‐Ping Yuan, Elda Righi et al. · Proceedings of the National Academy of Sciences · 2012 · 1.1K citations · Full text
Medicine, Immunology, Oncology +14
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Lin Tian, Amit Goldstein, Hai Wang et al. · Nature · 2017 · 852 citations
Medicine, Cancer Biology, Immunology +16
Inhibition of Mouse Sarcoma 180 by Polysaccharides from Lentinus edodes (Berk.) Sing.
Goro Chihara, Yukiko Maeda, Junji Hamuro et al. · Nature · 1969 · 664 citations
Medicine, Oncology, Pharmacology +8